Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Inflammatory Orbital Apex Syndrome in the Setting of COVID-19
Neuro-ophthalmology/Neuro-otology
Neuro-ophthalmology/Neuro-otology Posters (7:00 AM-5:00 PM)
024

There is an increasing awareness of neurologic manifestations and complications secondary to COVID-19. Our current understanding of the impact this virus has on the neurological system is limited. We present a case of a 25 year old man who presented to the emergency department with 1 week of double vision after being diagnosed with COVID-19.

Case report of inflammatory orbital apex syndrome in the setting of COVID-19.

NA

Starting at the time he was diagnosed with COVID 19, patient described a pulsating sensation in his right eye accompanied by blurry vision that progressed to diplopia and color desaturation. Patient did not have any recent trauma to his eye.  Exam was notable for a right afferent pupillary defect (APD) and the inability to adduct the right eye.  Fundi were normal, but he had decreased visual acuity of the right eye. Of note, the patient had a known history of left eye injury with chronic visual impairment. The rest of his cranial nerve exam was intact. MRI brain and orbits with and without contrast showed asymmetric abnormal enhancement in the right optic nerve sheath complex near the orbital apex concerning for inflammatory or infectious process. Extensive testing for infectious, inflammatory, demyelinating, vascular, and neoplastic etiologies were negative, including lumbar puncture. In consultation with ophthalmology and infectious disease, it was presumed that the patient developed an inflammatory orbital apex syndrome in the setting of COVID-19. He was treated with a five day course of high dose steroids after which he noted a significant improvement in visual acuity, color saturation, adduction, and diplopia. 

25 year old man presented with inflammatory orbital apex syndrome in the setting of COVID-19 infection. He responded to a five day course of high dose steroids. Our case report aims to increase awareness of neurologic manifestations associated with COVID-19.

Authors/Disclosures
Michelle Bravo, MD (University of Miami)
PRESENTER
Dr. Bravo has nothing to disclose.
Jessica Bloomfield, MD Dr. Bloomfield has nothing to disclose.
Anila Thomas, MD Dr. Thomas has nothing to disclose.